Sunwin ( SUWN ) explodiert !
--button_text--
interessant
|
witzig
|
gut analysiert
|
informativ
|
0
ist absolut cool
bei wallstreet-online gibt es trade gate , der is aber schlecht
Optionen
0
0
Class A Voting Com ($0.0001)
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
Stockguru.com: Guru Alerts for Wednesday, March 1, 2006 SUWN, FNIX, MOBL, CAMH.
Dallas, Texas, Mar 01, 2006 (M2 PRESSWIRE via COMTEX) -- Stock Guru Alerts for Wednesday include Sunwin International Neutraceuticals, Inc.(OTCBB:SUWN), Fonix Corporation (OTCBB:FNIX), MobilePro Corporation (OTCBB:MOBL), and Cambridge Heart, Inc. (OTCBB:CAMH).
To feature your publicly traded company in our alerts, email feature@stockguru.com or call (469)252-3031 and we will gladly send more information on featuring your company with StockGuru.com.
Sunwin International Neutraceuticals, Inc.(OTCBB:SUWN) closed down at 13.33%, trading 2,217,036 shares on Tuesday.
Sunwin International Neutraceuticals, Inc. (" Sunwin" ) (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, natural sweetener (Stevioside), and animal medicine prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality, value, and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz
Fonix Corporation (OTCBB:FNIX) remained unchanged at .02 per share, trading 8,133,909 shares on Tuesday.
Fonix Corporation (OTCBB:FNIX - News), based in Salt Lake City, is an innovative communications and technology company that provides integrated telecommunications services and value-added speech technologies through Fonix Telecom, Inc.; LecStar Telecom, Inc.; and The Fonix Speech Group. The combination of interactive speech technology and integrated telecommunications services allows Fonix to provide customers with comprehensive cost-effective solutions to enhance and expand their communications needs. Visit www.fonix.com for more information, or call 801-553-6600 and say " Sales."
MobilePro Corporation (OTCBB:MOBL) closed down at 2.66%, trading 2,164,280 shares on Tuesday.
MobilePro Corp. is one of North America's leading wireless broadband companies, serving over 20,000 wireless broadband customers through its subsidiaries NeoReach Wireless and Kite Broadband. The company, based in Bethesda, Md., is focused on creating shareholder value by acquiring and growing profitable telecommunications companies, developing innovative wireless technologies and forging strategic alliances with well-positioned companies in complementary product lines and industries. MobilePro serves more than 200,000 total customers throughout the United States with a broad array of telecommunications services.
Cambridge Heart, Inc. (OTCBB:CAMH) traded as much as 2.84% over open on Tuesday.
Cambridge Heart is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. Using innovative technologies, the Company is addressing such key problems in cardiac diagnosis as the identification of those at risk of sudden cardiac arrest. The Company's products incorporate its proprietary technology, Microvolt T-Wave Alternans, and are the only diagnostic tools cleared by the U.S. Food and Drug Administration to non-invasively measure microvolt levels of T-wave alternans. The Company, founded in 1990, is based in Bedford, Massachusetts and is traded on the OTCBB under the symbol CAMH. Cambridge Heart can be found on the World Wide Web at www.cambridgeheart.com
About StockGuru.com:
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit: http://www.stockguru.com/stocks.htm To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031. Our services include our Morning, Midday and After The Bell News Releases. Additionally we Profile publicly traded companies on our web site, we do interviews with CEO's or other key executives on our web site, and we have our financial writers cover our companies.
Those interested may also email: feature@stockguru.com and we will gladly send more information on featuring your company with StockGuru.com.
Stockguru.com (" SG" ) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.
This release contains " forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. " Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as " may" , " future" , " plan" or " planned" , " will" or " should" , " expected" , " anticipates" , " draft" , " eventually" or " projected" . You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements.
CONTACT: John Pentony, Publisher Tel: +1 469 252 3031 e-mail: feature@stockguru.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2006 M2 COMMUNICATIONS LTD
Optionen
0
Das wichtigste, und das habe ich mehrmals gepostet, SUNWIN hat ungeheuer potenzial in den kommenden monaten. also sogar 5000.-? werden sich ohne grösseres risiko binnen 12 monaten verdoppeln
Optionen
0
Also ich persönnlich rechne wie eben gesagt mit steigenden kursen aber wie lange und wie hoch, kann ich nicht sagen. Ist schwer hier im moment eine KURZFRISTIGE prognose zu geben. Auf 12 monate, wage ich hingegen eine 100% prognose.
Ich halte dich auf dem laufenden, wenn ich news habe oder dir helfen kann.
Optionen
0
0
0
SUNWIN INTERNAT NEUTRCTL - Nasdaq National Market: SUWN (A:SUWN.BE)
Chart-Export von RealTime US-Version V1.0.59
(Time: 01.03. 17:55)
SUNWIN INTERNAT NEUTRCTL - Nasdaq National Market: SUWN (A:SUWN.BE)
Last1.39Change (%) 0.09 (6.92)Trade Time11:56Bid (size) Tick1.38 (5) +Ask (size)1.39 (5)Day Volume678,547Latest Ticks==-=Prev Close1.30Open1.31Low1.26High1.44Avg Day Vol1,832,900# of Trades233Last Size546Avg Trade Size2,91252 Wk Low0.024152 Wk High1.51VWAP1.328
Orderbuch/Übersicht Export von RealTime US-Version V1.0.59
(Time: 01.03. 17:56)
Grüßles
US RealTime für nur 3,48Euro/mtl.
Optionen
0
0
Optionen
0
ich bin neu hier auf eurer seite, aber wollte doch auch mal meinen Senf dazu geben. Mir scheint es fast so, as würden hier viele (ganz sicher nicht alle!!;-)) wild darauf los spekulieren, ohne solides Wissensfundament über Sun Win..... wenn nicht die Vogelgrippe den Markt weltweit insgesamt kippt, so kann ich nur sagen: Irre, wer hoffe, sie würde nochmal deutlich unter einen Euro gehen und man könne da abzüglich aller Gebühren noch den dicken Fang machen..... Risiko ohne Gehirn, zumindestens in diesem speziellen Fall. Stevia wird 2007, wenn die EU Genehmigung als lebensmitteltauglich durch ist (und die kommt hundert pro durch!), mit Sicherheit noch einmal gigantisch in die Höhe schießen...und da vermutlich auch bleiben. Sun Win hat die größten und besten Stevia- Vertriebskontakte (unter anderm zu Coca cola u.ä. großen Marktriesen, die nur darauf warten, das sie ihre ekel-light Produkte auf gesunde und sehr schmackhafte Weise (wie bereits in China, USA und anderen Ländern geschehen)billig süssen können.Stevisoid(Konzentrat aus dem Pflanzenextrakt) ist etwa 300 x so süss wie Zucker, d.h. 1 gramm stevisoid = 300 gr. Zucker. Was coca cola da alleine an Zuckertransportkosten einsparen kann, ist gewaltig!Und es ist gesund, senkt aktiv den Diabetes, stärkt die Abwehrkräfte und pflegt/unterstützt die Zahngesundheit, regt den Stoffwechsel an, ist ein sehr gutes Kosmetikum, wird auch schon in Zahnpasten eingesetzt,eine attraktive Küchenpflanze, in warmen Ländern mehrjährig (bis zu 3 Ernten pro Jahr), kann von der Kulturart/den Bodenansprüchen sehr gut den rückläufigen Tabakanbau auf gleichen Feldern ersetzen,eröffnet gewaltige Möglichkeiten bei Schokoladen und anderen Süsswareneinsatz....a´la "Naschen ohne Reue", wird zum Ansetzen von Medikamentengrundlagen benutzt werden,ect. ect. ....
Dieses habe ich natürlich auch selbst ausprobiert, verschiedene Gerichte damit gekocht und selbst Griesbrei schmeckt sehr gut damit, kein Nebengeschmack. Leicht bittere Note tritt nur bei Überdosierung auf. Das kriegt man leicht in den Griff.
Wenn man dann noch ein paar andere, nicht uwesentliche Infos darüber hat, was Sun WIn noch so alles herstellt, ja, dann weiß man, das Ding KANN gar nicht schief gehen!
Ich bin gewöhnlich eher vorsichtig bis skeptisch, habe aber so auch noch nie Geld an der Börse verloren......hier kann ich nur sagen, bin ich sehr entspannt mit 50.000 Aktien eingestiegen..... für mich ein sehr gewagter Betrag...den ich niemals riskieren würde, wenn ich mir nicht 100 pro sicher wäre. ich rechne innerhalb von 1-1,5 Jahren mit einem Reingewinn von minimal 115.000 Euro.....wenn auch 200.000 wahrscheinlicher sind...Wer günstig gekaufte Aktien schnell wieder verscherbelt, ist in diesem Fall ganz klar am Ende auf der Verliererseite.....weil er mehr hätte bekommen können......also ich sage mindestens bis Mitte 2007 oder 2008 halten..... der EU Markt braucht auch etwas Zeit, sich nach der Zulassung zu entwickeln.
Das ist meine unmaßgebliche Meinung, ich hoffe, einigen haben die Hintergrundinfos zu stevia etwas genützt.
LG IraSofie
Optionen
0
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
Stockguru.com: Guru Alerts for Thursday, March 2, 2006 NXPW, NWBT, SUWN, SLGLF.
Dallas, Texas, Mar 02, 2006 (M2 PRESSWIRE via COMTEX) -- Stock Guru Alerts for Thursday include NextPhase Wireless, Inc. (OTCBB:NXPW), Northwest Biotherapeutics, Inc. (OTCBB:NWBT), Sunwin International Neutraceuticals, Inc. (OTCBB:SUWN), and Silverado Gold Mines, Ltd. (OTCBB:SLGLF).
To feature your publicly traded company in our alerts, email feature@stockguru.com or call (469)252-3031 and we will gladly send more information on featuring your company with StockGuru.com.
NextPhase Wireless, Inc. (OTCBB: NXPW) traded as much as 14.29% over open on Wednesday.
To view the StockGuru.com Profile for NextPhase Wireless, Inc. please visit: http://www.stockguru.com/profiles/nxpw/ NextPhase Wireless is a next-generation connectivity company that specializes in delivering integrated Internet, voice and data communication solutions to its customers. The Company designs, deploys and operates its own wireless networks and also provides wireless technology solutions to businesses and municipalities. The Company is an active member of the WiMAX Forum(TM) and the Wireless Communications Association International (WCA). Leveraging its full-service capabilities and world-class infrastructure, NextPhase Wireless offers a comprehensive portfolio of broadband solutions that meet customers' needs today, and can anticipate and grow to meet their needs of tomorrow.
Northwest Biotherapeutics, Inc. (OTCBB:NWBT) traded as much as 77.14% over open on Wednesday.
Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products that treat cancers more effectively than current treatments, without toxicity, on a cost-effective basis. The Company has two broad platform technologies: dendritic cell-based vaccines, and therapeutic antibodies. The Company's three lead product candidates are:
DCVax -Prostate, a personalized dendritic cell vaccine for treatment of hormone independent non-metastatic prostate cancer, which is entering a Phase III clinical trial recently cleared by the FDA ; DCVax -Brain, a personalized dendritic cell vaccine for treatment of newly diagnosed Glioblastoma multiforme, which is entering a large Phase II clinical trial recently cleared by the FDA; and monoclonal antibodies to CXCR4, which are in late preclinical development for the treatment of cancer. For further information, please visit the company web site at www.nwbio.com.
Sunwin International Neutraceuticals, Inc. (OTCBB:SUWN),traded as much as 10.77% over open on Wednesday.
Sunwin International Neutraceuticals, Inc. ("Sunwin") (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, natural sweetener (Stevioside), and animal medicine prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality, value, and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz.
Silverado Gold Mines, Ltd. (OTCBB:SLGLF) closed down at 7.69%, trading 26,149,790 shares on Wednesday.
Silverado has been exploring, developing and test mining gold deposits in central Alaska since 1978. The Company uses its varied technical skills to acquire, assess and develop gold deposits with the intention of conducting mining operations on worthy targets. From time to time partnerships or options are negotiated with other companies to assist in exploration of large areas of prospective property.
Silverado is also working on the development of a coal-based alternative fuel. The fuel would substitute for oil in the generation of electricity and industrial heat.
The Company is currently focusing on the Nolan Placer and Lode Gold Project north of Fairbanks.
About StockGuru.com:
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit: http://www.stockguru.com/stocks.htm To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031. Our services include our Morning, Midday and After The Bell News Releases. Additionally we Profile publicly traded companies on our web site, we do interviews with CEO's or other key executives on our web site, and we have our financial writers cover our companies.
Those interested may also email: feature@stockguru.com and we will gladly send more information on featuring your company with StockGuru.com.
Stockguru.com ("SG") provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements.
Disclosure: NextPhase Wireless, Inc. (OTCBB: NXPW) - Pentony Enterprises LLC was hired by Pasadena Capital Partners, our affiliate, and Pasadena was compensated 400,000 restricted rule 144 shares and 350,000 warrants exercisable at $0.30. Pasadena also anticipates receiving $72,000 in cash. Neither Pentony Enterprises LLC, nor our affiliates, are registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
CONTACT: John Pentony, Publisher Tel: +1 469 252 3031 e-mail: feature@stockguru.com
Optionen
0
0